The Use of High Activity Cobalt 60 Sources for Intracavitary and Surface Mould Therapy The use of low activity radium and other radioactive isotopes for the treatment of uterine and superficial skin cancer is associated with problems of radiation protection. In order to bring about a reduction in radiation exposure various afterloading systems have been described (Henschke 1960 , Martensen & Vikterlof 1962 , Horwitz et al. 1964 , Walstam 1962 .
A method of treating tumours using a system of afterloading was reported as early as 1910 when Abbe was quoted as using a system of celluloid tubes within a tumour (Archives of the Roentgen Ray 1910). These tubes were arranged to converge toward the centre of the tumour. This allowed the glass capsules, containing the radium salt, in use at that time, to be introduced into these tubes without difficulty. They were then left in position for the desired time. The advantages of the technique were those of practicality, the possible complications of radiation to staff not then being fully appreciated.
The recent introduction of high activity cobalt 60 sources as described by O'Connell et al. (1967) has enabled treatment times to be reduced to minutes. In this procedure the sources must be afterloaded into the treatment applicator by remote control. It also becomes necessary to carry out treatment within a radiation-protected room.
The radiation exposure dose received by staff can be greatly reduced by thtse methods. Table 1 shows the exposure dose received by 4 members of theatre staff mainly due to the treatment of uterine cervix cancer. The total body dose received during 1966, when radium only was used, was 10 rem. This was reduced to 2X1 rem in 1969 because the majority of patients were treated by Cathetron afterloading techniques. It can clearly be seen that the exposure dose has fallen with the reduction of the number of patients treated by radium.
The Cathetron machine consists essentially of a storage container which houses nine available 60Co source pencils of strength ranging from 1 to 5 Ci. The remote control mechanism allows up to three source pencils to be moved simultaneously into position at the treatment site. Each source pencil is carried within a semi-flexible tube which terminates in a stainless steel or plastic catheter. In order to maintain these source pencils accurately in position, relative to the patient's tissues, some form of treatment applicator is necessary. This applicator is maintained in position by a series of clamps in order to carry out either surface or intracavitary treatment.
The clinical advantages for this form of therapy include: (1) A reduction in treatment time from days or hours to only a few minutes. It is, therefore, a relatively simple process to maintain the (2) Fractionation of treatment on a daily basis and combined concurrent external beam therapy may be given. (3) Extension of treatment over several weeks with modification of treatment depending upon tissue response.
In situations such as treatment for cervical cancer concurrent fractionated treatment by intracavitary and external beam therapy allows the isodose distribution to be carefully controlled. Fig 1 illustrates the isodose distribution across the pelvis obtainable by combined therapy. The Cathetron delivers radiation to the central volume. The external beam therapy is given through wedged fields in order to compensate for the fall off in dose from the Cathetron treatment at the iliac and obturator nodes and to limit the dose received by the rectal and bladder tissues. The combined effect, therefore, is to deliver extremely high doses of radiation to the cervix and at the same time to reach a cancerocidal dose in the pelvic lymph nodes.
Radiobiological Implications
The dose rates obtainable from radium, for the quantities used in practice, range from less than 1 rad to over 3 rads a minute. The Cathetron allows dose rates to be increased up to 400 rads a minute. The effect of a change of dose rate, for rates ofless than about 20 rads a minute, is to produce a change in radiobiological effect. The implications of this have been reviewed by Liversage (1966) , Joslin et al. (1967) and Joslin (1970) . Whereas, for the range of dose rates obtainable from the Cathetron no change in radiobiological effect is to be expected, for radium this is not the case. We cannot, therefore, simply equate our experience for radium to Cathetron therapy despite the similarity of isodose distribution.
When considering the radiobiological effect, in terms of dose rate, of radiation of 0 3 rads a minute from intracavitary radium at the pelvic wall, and 3 5 rads a minute at the cervix, the effect at the cervix can be shown to be about 1 25 times greater than that at the pelvic wall. However, when the corresponding Cathetron dose rates of 30 rads and 400 rads a minute are considered this difference in effect does not exist. A comparison of the effect of Cathetron dose rates, for a single dose, against a dose rate of 1-4 rads a minute for radium, maintained for twenty-four hours, will increase the effect by approximately 60%.
Further support for an increased radiobiological effect at the higher dose rates can be deduced from clinical experience for radium implants where, as the dose rate is increased, the tumour lethal dose decreases. Curves relating these doses to the overall treatment time, and therefore dose rate, have been published by Ellis (1963) and Paterson (1963) . In both curves the ratio of the doses necessary in twenty-four hours to a single acute dose of, say, 2,000 rads is about 1-7: 1 Similarly, the ratio derived from Cowell's (1938) work on minimum tumour lethal doses is about 1-6: 1. By using the 'Ellis' curve an equivalent highdose-rate dose can be determined for each radium insertion.
The three regimes of treatment with which we are concerned are summarized in Table 2 from which it can be seen that the single equivalent doses derived for each of these treatment modalities are comparable; these calculations were made using the dose-response curve data published by Fowler (1966) .
Oxygen Effects Oxygen effects are also possibly of importance. Evidence exists (Hall et al. 1966 ) which suggests that the oxygen enhancement ratio for low dose rates is lower than that at high dose rates. It has also been suggested (Bedford & Hall 1966 ) that this low ratio will reduce the protective effects of hypoxia. For high dose rates this would be overcome to some extent by fractionation of treatment, which would possibly allow some reoxygenation to take place between treatments. However, more evidence is necessary before a critical evaluation of the part played by oxygen tension for the different dose rates can be made.
Patient Considerations
When considering the effect of any new method of treatment it is important to balance possible clinical advantages against possible inconvenience to the patient. It is also important that the patient's well-being and chance of cure should not be jeopardized, which is always the most difficult criterion to fulfil. Because of this some form of prospective clinical trial may be necessary but, on the other hand, if current treatment practice offers only a small chance of cure it may be considered that a trial is unnecessary.
The immediate advantage to patients receiving Cathetron treatment is the greatly reduced inconvenience to them. They are not committed to bed for up to a week as they are when treated by radium and can, in many cases, be treated on an out-patient basis. Also, the stigma of having a radium notice on the foot of the bed is removed, the effect of which is often overlooked. Because of the elimination of radiation exposure more time can be given to nursing procedures where necessary. The elimination of a vaginal pack and urethral catheter produces greater comfort and allows free vaginal drainage.
Radical Treatment ofCervix Cancer Over a period of two years more than 60 patients have been treated on a radical basis. Initial treatment is given using the Cathetron, immediately following assessment under anmsthesia. Treatment is repeated weekly for three weeks, giving four treatments altogether. Over this same period twelve fractions of concurrent external beam therapy, using 60Co, are given. Patients are mostly those with Stage II and III carcinoma, but more recently Stage I cases have been included.
Since the series first started the numbers of patients entering treatment in each six-month ot 0 The symptomatic effects of treatment are those of diarrhoea and occasionally lower abdominal pain. As this may indicate small bowel reactions, treatment is curtailed until reactions settle. Approximately 20% of patients develop some symptom associated with treatment and this is mostly diarrhoea, which usually responds to simple treatment measures and patients are not unduly inconvenienced.
Post-operative Treatmentfor Carcinoma ofCorpus Uteri The use of radium as a post-operative procedure to treat the vaginal vault tissues in order to reduce secondary recurrence is well known. A technique using a vaginal obturator loaded by the Cathetron :R Z-has been mentioned by Joslin et al. (1969) . The applicator we use is illustrated in Fig 3 and replaces the normal type of radium applicator described by Dobbie (1953) . Tubes of various diameter are available and can be inserted within the vagina and held in position by a simple clamping device. The isodose distribution follows the shape of the applicator and enables a high dose of radiation to be delivered to the vaginal epithelium in a homogeneous fashion. Treatment can again be given on a simple fractionated basis with similar advantages as for the cervix cases. The results of this form of therapy are being published (Joslin & Smith 1970) .
Applicatorsfor the Treatment ofSkin Cancer A measure of the success and acceptance of treatment for superficial skin cancer, by means of ionizing radiation, is the destruction of the tumour with minimal damage to the associated normal structures. The amount of normal tissue damage that can be accepted will vary with the treatment site and require particular attention for tendons, cartilage or bone. It is also important that the volume of tissue which receives a cancerocidal dose shall be kept to a minimum, especially the connective tissues of the stroma; other factors to be considered are the quality of ionizing radiation used, the radiation dose rate, overall dose, time and dose fractionation relationships. The commoner treatment methods of high dose rate, fractionated superficial X-ray therapy and low dose rate, continuous or interrupted radium mould therapy are well known. The treatment distance for superficial X-rays is usually between 15 and 20 cm and for radium therapy up to 2 cm. Treatment distances greater than 2 cm are not usually used for radium because of the difficulty in handling large quantities of unshielded isotope. This hazard not only affects staff, but as the treatment distance increases the dose to the tissues surrounding the treatment area also increases.
When comparing the depth dose data for superficial X-rays and short distance gamma therapy the fall-off in dose for soft tissues will take the form shown in Fig 4. From this it can be seen that the dose distribution in terms of 'fall off' will be similar for the two treatment modalities. Therefore, any difference in clinical effect for the two methods of treatment, corrected for relative radiobiological efficiency, could be ascribed to a difference in fractionation regime or a difference in dose rate.
By the use of afterloading techniques of the type described by Joslin et al. (1969) it is now possible to use the Cathetron as a method of treatment. This makes it possible to increase dose rates to 100 rads or more per minute for the same treatment distance as used for radium. If the same fractionation regimes are used as in superficial X-ray treatments, any possible difference in radiobiological effect would be dependent only on the quality of radiation used. However, Liversage (1969) has derived a mathematical relationship for determining high dose rate fractionated regimeswhich should be biologically equivalent to the previously used low dose rate radium therapy. Comparison with radium therapy, however, involves a consideration of many factors including the dose rate, total treatment time, the dose per fraction and total number of fractions. Certain assumptions have also to be made concerning the recovery of sublethal damage and repopulation of the tumour during irradiation by the two different methods. The only factor which is not changed is the radiation quality RBE. Although Liversage derives doses similar to those used by us, we feel that a simpler estimate of the treatment doses necessary can be derived from comparison with the superficial X-ray doses used, for which the necessary correction factor has been in use for many years. Therefore, any difference of RBE can be allowed for when calculating an equivalent dose, and it then becomes a simple matter to prescribe treatment. The main advantage for high dose rate, short distance, radiocobalt therapy against superficial X-ray therapy is thus one of quality of radiation alone. This becomes especially import-0 00 0. for superficial X-rays andshort distance gamma rays for these depth dose data Other effects of quality of radiation on tissue response have been studied by Koller (1959) and the advantages for using high energy gamma radiation stressed.
The treatment techniques vary to suit the type of case and have already been discussed by Joslin et al. (1969) . Treatment is usually given in 8 fractions over nine days to a skin dose of 5,000 rads. For tumour sites involving the pinna or back of the hand this dose is reduced to 4,500 rads. The cases chosen are those where normal tissues might well be expected to suffer the least damage as a result of treatment using gamma radiation. Skin healing and the final cosmetic effects are observed to determine whether these are improved against superficial X-ray or radium mould therapy. No form of prospective stratified trial has been attempted.
Because there is no longer any worry regarding radiation hazard the treatment distance can be increased to 2-3 cm. This improves the homogeneity of dose distribution within a tumour volume especially when contained within an area which is irregular, such as the pinna. This does, however, raise problems with respect to protecting adjacent tissues. Some form of protection can be achieved by surrounding the treatment area with lead in the form of a cut-out. A typical case is illustrated in Fig 5A, where the lesion is a squamous cell carcinoma at the junction of the helix and face. Fig 5B shows the treatment set-up with the lead protection around the treated area to improve collimation. Fig 5c shows the treated region three months later. Fig 6 indicates the ease with which a lesion on the dorsum of the wrist may be treated whilst protection is offered to the patient as a whole by placing a bridge of lead over the hand during treatment.
So far a total of 65 patients have been treated by these high dose rate techniques. The cosmetic results achieved, possibly as a result of high quality radiation confined to a small volume and a wide penumbra, have been equal to any of the other radiation modalities that could have been used. Dr D Gamble (Essex County Hospital, Colchester) A Technique for Afterloading Implants Using Radioactive Iridium Wire [Summary] In 1910 Abbe described a technique of implanting rubber tubes into the middle of a tumour and subsequently inserting glass capsules containing radium salts.
Little interest was shown in afterloading techniques for the next forty years until Henschke et al. (1963) developed a method of inserting plastic tubes into a tumour and then at a later date threading in radioactive iridium seeds contained in inner tubes. The advantages claimed for this method were: lower radiation exposure to staff, better availability and greater accuracy.
This method was later modified by Pierquin (Pierquin & Chassagne 1962) to use thin 0 3 mm diameter iridium 192 wire instead of iridium 192 seeds. He also described a method of using iridium wire hair pins in the tongue after previously inserting guiding gutters (Pierquin etal. 1959) .
Iridium 192 has considerable advantages as an isotope for interstitial therapy: (a) It is obtainable as thin 0 3 mm diameter wire which can be loaded into narrow plastic tubing and is flexible.
(b) Thicker material, 0 5 mm diameter, is available which can be used unsupported as hairpins in, say, the tongue or bladder. (c) It can be obtained in a wide range of specific activities to suit many different applications. (d) The mean energy of its y-rays is much less than that of radium, tantalum 182 or cobalt 60; therefore, protection is much easier.
The only real disadvantage is its short half-life of 74 days.
TheHenschke-Pierquinmethod of implantation is simple:
(1) Hollow needles are inserted as required.
(2) A steel stilette is inserted into each needle.
(3) Outer plastic tubing is placed over the stillette. (4) The stilette is grasped through the plastic tubing and the needle is then pushed by the plastic tubing out through the exit hole.
(5) This leaves the plastic tube in the position previously occupied by the needle. (6) The tube is trimmed for the length and held in place by fixation buttons. (7) Non-radioactive wire is placed in each tube and check radiographs taken. (8) From the radiographs the dosimetry is done and the iridium ordered. (9) The iridium wire is inserted into inner plastic tubes.
(10) The inner tubes are inserted into the outer tubes and held firmly in place by crimping the buttons.
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Afterloading Techniques
Afterloading techniques have been in use for some time. Their advantages are that the radiation dosage to theatre staff is small and that insertions can be as deliberate as necessary without the fear of occupational irradiation of the radiotherapist or ancillary staff. In addition, precalculation before loading makes possible adjustments to improve dosage distribution as well as facilitating the timing of commencing the radiation so as not to prejudice healing of wounds. Removal of the radioactive sources can be conveniently timed; they can be removed at different times if necessary to improve dosage distribution.
Methods
Various techniques have been used: Radium has been afterloaded in gynecological treatment. Also radium needles can be afterloaded into steel needlesto treat the axillary lymph nodesand in plastic tubes in connexion with operative removal of cancers. The disadvantage of the implantation methods is chiefly that the tubes are so thick. Tantalum 182 or iridium 192 in the form of wire may be used in tubing as may also chains of seeds. Thin steel tubing into which bare wire is inserted can be used or wider plastic tubing into which thinner tubing containing the radioactive-wire can
